End-stage Renal Disease Costs for Patients New to Hemodialysis in Italy: The FARO-2 Study
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 12, Issue 5
Abstract
Background: Increasing incidence and prevalence of end-stage renal disease (ESRD) together with the presence of several comorbidities in chronic kidney disease patients (CKD) could be associated with a relevant economic burden. Aim: The aim of this analysis was to estimate the direct healthcare costs of ESRD and its major comorbidities in Italian patients who were naïve to hemodialysis (HD) recruited for the FARO-2 study. Methods: The FARO-2 study was a retrospective observational study conducted in Italy that evaluated the patterns of treatment of secondary hyperparathyroidism (SHPT) and related costs in patients naïve to HD. The observational period was 2006–2008. Costs were measured in Euros (reference year: 2008). Resource use for the first 2 periods of 6 months of HD was monetized, with reimbursement calculated for SHPT drugs, phosphate binders, and erythropoietin-stimulating agents (ESAs); HD sessions; and hospitalizations due to ESRD and its major comorbidities. The analysis was performed by the Italian National Health Service (INHS) perspective. Results: 567 patients were observed for at least 2 periods of 6 months. During the first 12 months after the initiation of HD, average direct healthcare costs were assessed using the percentage of patients treated and the average daily dosages (for drugs), the percentage of patients hospitalized and the types of hospitalizations (for inpatients), and the average weekly frequency of HD sessions. Total per-patient yearly costs totaled 34,789.9 €: HD accounted for 66.1% of expenditures, with hospitalizations and drugs accounting for 12.9% and 21.0% of expenditures, respectively (including 17.1% for ESAs). Conclusions: Patients naïve to HD have a significant impact on Italian National Health Service expenditures, although only the costs related to treatment of ESRD and its comorbidities were calculated in the present study. The major cost drivers were HD and ESAs, while SHPT drugs and phosphate binders together accounted for only 3.9% of direct healthcare expenditures.
Authors and Affiliations
Daniela Paola Roggeri, Alessandro Roggeri, Diego Brancaccio, Sandro Mazzaferro, Piergiorgio Messa, Ernesto Paoletti, Anna Maria Costanzo, Umberto di Luzio Paparatti, Mario Cozzolino
Relationship between Glycated Hemoglobin and Serum Lipid Profile in Type 2 Diabetes Mellitus – A Case-control Study
Aims: The aim of the study is to find whether there is any relationship between glycated hemoglobin level and serum lipid profile in type 2 diabetes mellitus patients. Study Design: A total of 128 study participants were...
Metabolic Syndrome: Modification of the Fatty Acid Composition and Glucose-insulin Homeostasis
Objective: Metabolic syndrome is a widespread disease associated with cardiovascular pathologies and diabetes mellitus. The underlying mechanisms for development of the metabolic syndrome are currently being intensively...
Child Attention-Deficit Hyperactivity Disorder (ADHD) in Same-Sex Parent Families in the United States: Prevalence and Comorbidities
Aims: This paper presents the first population data on attention-deficit hyperactivity disorder (ADHD) among children raised by same-sex parents with the aims 1) to test whether residence with same-sex parents is associa...
Protection Effect of Different Fractions of Root of Lawsonia inermis on 2-Deoxyribose by Hydroxyl (.OH) Radical Assay
Aim: In vitro protective effect of different fractions of root of Lawsonia inermis (LI) on 2-deoxy ribose, sugar of the DNA were carried out in this study. Methods: Protective activity of different fractions of LI namely...
Analysis of Bone-implant Interfacial Stress during Disocclusion in Complete Implant-supported Prosthesis: A Finite Element Study
Aim: Little is known about the biomechanical behavior of disocclusion patterns in implant-supported prostheses. Thus, the aim of the present study was to analyze the stresses generated at bone-implant interface during di...